Structure Therapeutics Statistics
Total Valuation
GPCR has a market cap or net worth of $1.41 billion. The enterprise value is $582.49 million.
Important Dates
The next estimated earnings date is Friday, May 23, 2025, after market close.
| Earnings Date | May 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GPCR has 57.34 million shares outstanding. The number of shares has increased by 30.50% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 57.34M |
| Shares Change (YoY) | +30.50% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 5.82% |
| Owned by Institutions (%) | 102.95% |
| Float | 49.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.72 |
| P/TBV Ratio | 1.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.29, with a Debt / Equity ratio of 0.01.
| Current Ratio | 23.29 |
| Quick Ratio | 22.94 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -22.85% and return on invested capital (ROIC) is -18.01%.
| Return on Equity (ROE) | -22.85% |
| Return on Assets (ROA) | -17.24% |
| Return on Invested Capital (ROIC) | -18.01% |
| Return on Capital Employed (ROCE) | -21.99% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$879,282 |
| Employee Count | 163 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, GPCR has paid $379,000 in taxes.
| Income Tax | 379,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.27% in the last 52 weeks. The beta is -1.79, so GPCR's price volatility has been lower than the market average.
| Beta (5Y) | -1.79 |
| 52-Week Price Change | -31.27% |
| 50-Day Moving Average | 21.30 |
| 200-Day Moving Average | 30.83 |
| Relative Strength Index (RSI) | 54.67 |
| Average Volume (20 Days) | 1,174,293 |
Short Selling Information
| Short Interest | 9.14M |
| Short Previous Month | 7.02M |
| Short % of Shares Out | 15.93% |
| Short % of Float | 18.40% |
| Short Ratio (days to cover) | 7.91 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -182.52M |
| Pretax Income | -100.26M |
| Net Income | -143.32M |
| EBITDA | -181.48M |
| EBIT | -182.52M |
| Earnings Per Share (EPS) | -$2.59 |
Full Income StatementBalance Sheet
The company has $836.88 million in cash and $7.59 million in debt, giving a net cash position of $829.30 million or $14.46 per share.
| Cash & Cash Equivalents | 836.88M |
| Total Debt | 7.59M |
| Net Cash | 829.30M |
| Net Cash Per Share | $14.46 |
| Equity (Book Value) | 824.64M |
| Book Value Per Share | 14.33 |
| Working Capital | 813.14M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$134.79 million and capital expenditures -$1.44 million, giving a free cash flow of -$136.23 million.
| Operating Cash Flow | -134.79M |
| Capital Expenditures | -1.44M |
| Free Cash Flow | -136.23M |
| FCF Per Share | -$2.38 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |